(3aR,4R,5R,7S,8S,9R,9aS,12R)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluor o-1-hydroxy-1,3-dihydrobenzo[C][1,2]-oxaborol-6-yl)oxy)acetate

CAS : 2130750-59-1

Ref. 3D-FKD75059

Informations sur le produit

• Nom: (3aR,4R,5R,7S,8S,9R,9aS,12R)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluor o-1-hydroxy-1,3-dihydrobenzo[C][1,2]-oxaborol-6-yl)oxy)acetate
• Marque: Biosynth
• Description: (3aR,4R,5R,7S,8S,9R,9aS,12R)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydrobenzo[C][1,2]-oxaborol-6-yl)oxy)acetate is a novel antifungal compound derived from boron chemistry, representing a new class of therapeutic agents in the field of antifungal treatments. The compound primarily originates from the synthesis and refinement of boron-based molecular scaffolds, yielding a structure capable of disrupting fungal growth through a unique mode of action. It functions by inhibiting the fungal enzyme leucyl-tRNA synthetase, which is crucial in protein synthesis and thus vital for fungal cell survival and proliferation. By targeting this specific enzyme, the compound effectively halts the production of essential proteins, leading to the cessation of fungal growth and eventual cell death. The primary application of this compound is in the treatment of a range of fungal infections, particularly those that are resistant to conventional antifungal drugs, offering a potent alternative in clinical settings. The application of this compound spans both topical and systemic treatments, addressing a critical need for more effective antifungal therapies.

Propriétés chimiques

• Masse moléculaire: 528.4 g/mol
• Formule: C₂₉H₃₈BFO₇
• Degré de pureté: Min. 95%